Related Experiment Video

Updated: Aug 12, 2026

Cardiac Stress Test Induced by Dobutamine and Monitored by Cardiac Catheterization in Mice
15:45

Cardiac Stress Test Induced by Dobutamine and Monitored by Cardiac Catheterization in Mice

Published on: February 10, 2013

Postresuscitation left ventricular systolic and diastolic dysfunction. Treatment with dobutamine

K B Kern1, R W Hilwig, R A Berg

  • 1University Heart Center, Tucson, AZ, USA. kernk@u.arizona.edu

Circulation
|June 17, 1997
PubMed

Insights

Early dobutamine administration after cardiac arrest improves heart function. This treatment helps overcome post-resuscitation systolic and diastolic left ventricular dysfunction, enhancing survival after sudden cardiac death.

Area of Science:

  • Cardiology
  • Critical Care Medicine
  • Pharmacology

Background:

  • Global left ventricular dysfunction is a significant factor limiting survival after cardiac arrest and resuscitation.
  • Post-resuscitation myocardial dysfunction remains a critical challenge with limited treatment options.
  • Previous studies have not investigated interventions for this specific condition.

Purpose of the Study:

  • To investigate the efficacy of dobutamine in treating post-resuscitation left ventricular dysfunction.
  • To evaluate the impact of dobutamine on both systolic and diastolic cardiac function after cardiac arrest.
  • To determine if early dobutamine intervention can mitigate the negative effects of resuscitation on heart function.

Main Methods:

  • 27 swine underwent prolonged ventricular fibrillation cardiac arrest and successful resuscitation.
  • Left ventricular systolic and diastolic function parameters were measured pre- and post-resuscitation.
  • Dobutamine infusions (5 or 10 micrograms.kg-1.min-1) were administered 15 minutes post-resuscitation and compared to a control group.

Main Results:

  • Dobutamine treatment ameliorated the deterioration of systolic and diastolic left ventricular function observed in controls.
  • Left ventricular ejection fraction remained stable in the dobutamine group (10 micrograms.kg-1.min-1) post-resuscitation, unlike the control group.
  • Dobutamine infusion prevented the rise in the isovolumic relaxation constant (tau), indicating improved diastolic function.

Conclusions:

  • Early administration of dobutamine (within 15 minutes) effectively overcomes post-resuscitation systolic and diastolic left ventricular dysfunction.
  • Dobutamine treatment offers a potential therapeutic strategy to improve outcomes after cardiac arrest and cardiopulmonary resuscitation.
  • This study highlights dobutamine's role in managing myocardial dysfunction following resuscitation from cardiac arrest.
Abstract

More Related Videos

Transthoracic Echocardiography to Assess Post-Resuscitation Left Ventricular Dysfunction After Acute Myocardial Infarction and Cardiac Arrest in Pigs08:19

Transthoracic Echocardiography to Assess Post-Resuscitation Left Ventricular Dysfunction After Acute Myocardial Infarction and Cardiac Arrest in Pigs

Published on: July 12, 2022

Pulsed Wave Doppler Assessment of Diastolic Dysfunction in the ZSF-1 Rat Model of Pulmonary Hypertension Due to Left Heart Disease08:57

Pulsed Wave Doppler Assessment of Diastolic Dysfunction in the ZSF-1 Rat Model of Pulmonary Hypertension Due to Left Heart Disease

Published on: May 22, 2026

Related Concept Videos

Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...